The involvement of BRAF in T cell exhaustion was further supported by its inhibition and following significant reestablishment of anti-tumor T cell responses, implying the potential role of BRAF inhibitors in immune-based therapies (83). The gene discussed is BRAF; the disease is neoplasm.